C93.0
Acute monoblastic/monocytic leukemia
Clinical Classification Guidelines
Inclusion Terms
- AML M5
- AML M5a
- AML M5b
Medical Intelligence & Overview
Acute monoblastic/monocytic leukemia, classified under ICD-10 code C93.0, is a type of blood cancer that primarily affects the monocyte cells, a subgroup of white blood cells. This form of leukemia is characterized by the rapid growth of monoblasts and monocytes in the bone marrow and blood, leading to a suppression of normal blood cell production. It is one of the subtypes of acute myeloid leukemia (AML), specifically categorized as AML M5. The disease can progress swiftly if not treated properly, impacting various functions of the body due to the disruption of normal blood cell levels.
Causes & Symptoms
Clinical Causes: Genetic mutations or chromosomal abnormalities Previous exposure to chemotherapy or radiation therapy Exposure to certain chemicals such as benzene Inherited genetic disorders such as Down syndrome Idiopathic (unknown causes)
Key Symptoms: Fatigue and weakness Fever and recurrent infections Easy bruising or bleeding Pale skin due to anemia Bone or joint pain Swelling in the gums Unintended weight loss Shortness of breath Night sweats
Diagnostic & Treatment
Diagnosis Path: Diagnosing acute monoblastic/monocytic leukemia involves several steps, including:
Treatment Protocols: Treatment strategies for acute monoblastic/monocytic leukemia typically involve aggressive approaches aimed at eradicating leukemia cells and restoring normal blood cell production. Standard treatments include:
Clinical Advice & FAQs
Billing Guidance
Is C93.0 a billable ICD-10 code?
Yes, C93.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C93.0?
Clinical documentation must specify the nature of Acute monoblastic/monocytic leukemia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference